Percentage of patients aged 18 years and older, who are evaluated for hearing loss and complete a hearing loss self-assessment tool that indicated an impact of hearing-related quality of life (QoL), and if diagnosed with a bilateral moderate to profound sensorineural hearing loss (SNHL) and less than 60% open set speech recognition are scheduled or referred for cochlear implant candidacy testing AND for patients who undergo cochlear implantation, demonstrate a meaningful clinically important difference (MCID) improvement in self-assessment of Hearing-related QoL or an improvement in speech recognition within 18 months of cochlear implant activation.
Strata 1: Patients aged 18 years and a patient encounter
Strata 2: Patients aged 18 years and older who are diagnosed with a bilateral moderate to profound SNHL that impacts their quality of life, and less than 60% open set speech recognition, are scheduled or referred for cochlear implant candidacy testing. ORPatient completed a self-assessment tool that indicated an impact of hearing QoL, received a hearing loss assessment procedure, was diagnosed with bilateral moderate to profound SNHL and less than 60% open set speech recognition but has not yet had a trial with amplification so was not scheduled or referred for cochlear implant candidacy testing.
Strata 2: Patient declined or is unable to complete post-cochlear implant self-assessment tool, medical/patient/system reason provided within 18 months of cochlear implant activation.
NQF ID Number
Effective Clinical Care
High Priority Measure
Continuous Variable Measure
Number of performance rates to be calculated and submitted
Patient Reported Outcome (PRO)
Ambulatory Care: Clinician Office/Clinic